Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 13Phase 1/2 13Phase 1 13Phase NA 1Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 10Breast 6Other hematologic neoplasm 4Genitourinary 4Gynecologic 3Myeloid 2Lymphoid 2Head & Neck 2Tumor-Agnostic 1Thoracic 1Endocrine 1

Conditions

Lung Neoplasms 1

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Injections × Thoracic × Clear all
NCT05631028 2023-03-14

95% Effective Dose(ED95) of Remimazolam During Dexmedetomidine Pretreatment

Shanghai Pulmonary Hospital, Shanghai, China

Phase NA Completed
115 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡